Health

Truveta welcomes new well being system members and raises $95M; YuLife scores $70M to remodel life insurance coverage and extra digital well being fundings



Truveta, a provider-led startup making a complete platform of de-identified affected person information, has raised $95 million in Collection A funding.

The corporate’s well being techniques, together with its three newest members Baylor Scott and White Well being, MedStar Well being and Texas Well being Sources, contributed to the funding spherical. With the brand new additions, Truveta’s members present 15% of all affected person care within the U.S., in accordance with the announcement.

“I am impressed by the dedication from our 17 well being supplier members to hitch Truveta to save lots of lives with information,” Terry Myerson, CEO of Truveta, mentioned in an announcement.

“Collectively, we’re laborious at work to assist researchers discover cures sooner, empower each clinician to be an skilled, and assist households know they’re receiving the very best care for his or her situation. We’re constructing an unprecedented information platform and studying group for well being. Our members’ information dedication, scientific experience, and strategic capital will assist us obtain our imaginative and prescient. We invite others to hitch us.”

Truveta plans to make use of the funding to rent technologists and well being information consultants who may help it construct the platform. The money may also go towards masking infrastructure and cloud-computing prices associated to creating the Truveta platform.

London-based insurtech startup YuLife scored $70 million in a Collection B funding spherical led by Goal International. Extra assist got here from new buyers Eurazeo and Latitude in addition to present buyers Creandum, Notion Capital, Anthemis, MMC Ventures and OurCrowd.

On a mission to remodel conventional life insurance coverage, YuLife’s app harnesses gamification, behavioral science and synthetic intelligence to encourage members to observe wholesome behaviors. It rewards members once they full actions reminiscent of understanding or meditating and provides employers actionable information insights.

“For too a few years, life insurance coverage has targeted solely on paying out a lump sum upon dying. It’s now time to reimagine the very nature of life insurance coverage by placing ‘life’ first, and galvanizing members to dwell their finest lives each single day, utilizing insurance coverage as a software to reinforce their bodily, psychological and monetary wellbeing,” Sammy Rubin, CEO and founding father of YuLife, mentioned in an announcement. “Redefining group-life insurance coverage is simply the beginning of the journey for YuLife as we glance to encourage life by way of an enormous vary of latest insurance coverage merchandise.”

YuLife plans to make use of the funds to develop new merchandise, broaden its presence within the UK and broaden its attain into new markets.

AI-enabled drug discovery firm Entos right this moment introduced the closing of its $53 million Collection A funding spherical.

Coatue led the spherical together with Catalio Capital Administration, OrbiMed, Sequoia Capital, Nexus Ventures and Freeflow.

Entos’ lead product, the OrbNet platform, is powered by synthetic intelligence and machine studying and accelerates quantum mechanics calculations whereas utilizing much less coaching information to create an improved drug improvement course of.

The funding will go towards constructing out the OrbNet platform, particularly with robotic synthesis and high-throughput experimentation, in addition to supporting Entos in hiring further scientific and engineering expertise.

Decentralized scientific trial startup Castor raised $45 million in Collection B funding led by Eight Roads Ventures and F-Prime Capital. This spherical brings the corporate’s complete funding pot to $65 million.

Present buyers Two Sigma Ventures and Inkef Capital additionally participated within the elevate.

“Castor was created with the mission to assist researchers globally conduct more practical scientific trials whereas bettering the affected person expertise,” Dr. Derk Arts, CEO and founding father of Castor, mentioned in an announcement. “Prioritizing the affected person and website consumer expertise is especially vital right this moment when COVID-19 has basically modified the character of scientific trials.”

The corporate will use the brand new capital to make enhancements to its platform, focusing significantly on globally scaling direct-to-patient trials.

Swift Medical, a digital wound care firm, introduced a Collection B funding spherical price $35 million. Virgo Funding Group led the spherical along with DCVC, BDC Capital, Claritas Capital, Chrysalis Ventures, Pender Ventures and Export Growth Canada.

The corporate’s platform harnesses AI to seize the size and scientific traits of a wound and consultations and real-time predictive insights into care and prevention.

“Wound care is an enormous scientific and monetary problem at each bedside, which has been largely ignored by the expertise business,” Carlo Perez, cofounder and CEO at Swift Medical, mentioned in an announcement.

“By COVID-19, well being techniques have been waking as much as the necessity to equip their clinicians with empathic expertise that provides them the information and confidence to supply world-class wound look after even their most advanced, bedridden sufferers.”

Swift Medical will use the funds to scale its platform throughout North America, in accordance with the announcement.

Russian insurtech firm BestDoctor has raised $26 million in Collection B funding, as reported by TechCrunch. Winter Capital Companions, VNV International and UNIQA Ventures participated within the elevate.

The corporate creates expertise insurance coverage merchandise for employers and affords telemedicine companies for workers.

Whereas BestDoctor did not specify what precisely the funds might be used for, it has plans to enter the patron market this yr in addition to broaden to a worldwide market.

 



Supply hyperlink

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *